Caution about ketoacidosis, UTIs, and other serious ADRs with the SGLT2s

More warnings for the SGLT2 inhibitors (Invokana, etc) will increase concerns about their safety.

These "flozins" are sometimes preferred because they have a low risk of hypoglycemia...lead to modest weight loss...and can lower BP.

Plus Jardiance (empagliflozin) has CV benefits including a reduced risk of cardiovascular death and heart failure hospitalizations.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote